1. 5% Lidocaine Hydrochloride Cream for Wound Pain Relief: A Multicentre Observational Study
- Author
-
Teresa Oranges, Chiara Stocco, Agata Janowska, Giovanni Papa, Valentina Dini, Marco Romanelli, Giulia Davini, Zoran Marji Arnez, Papa, G., Janowska, A., Romanelli, M., Davini, G., Oranges, T., Stocco, C., Arnez, Z. M., and Dini, V.
- Subjects
Adult ,Male ,Adolescent ,Lidocaine ,Administration, Topical ,Pain ,wound healing ,Lidocaine Hydrochloride ,Topical anesthetic ,Wound pain ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Prospective Studies ,Anesthetics, Local ,Acute pain ,Aged ,Pain Measurement ,Aged, 80 and over ,integumentary system ,business.industry ,Chronic pain ,acute pain ,Middle Aged ,medicine.disease ,chronic pain ,topical anesthetic ,030220 oncology & carcinogenesis ,Anesthesia ,Wounds and Injuries ,Female ,030211 gastroenterology & hepatology ,Surgery ,Observational study ,Wound healing ,business ,medicine.drug - Abstract
Background: Lidocaine hydrochloride is frequently used for management of painful wounds. This prospective, multicentre study examined the effects of 5% lidocaine cream on wound pain relief. Material and methods: The study included 78 patients with painful wounds treated with 5% Lidocaine cream for two weeks in two Italian Hospitals. Patients’ perception of pain was recorded by, using the 5-point Visual Rate Scale and the 11-point Numerical Pain Rating Scale. All medications and adverse events were evaluated in a daily diary. The primary outcome of the study was establishing the wound pain relief based on the results of 5-VRS and pain intensity based on the 11-NPRS testing from baseline to the end of treatment. Clinical aspects and adverse events were also collected. Results: Seventy-eight patients had a median age of 67.5 years (range 18-96 years). 62.8% were women. The wounds included traumatic wounds (n = 39), venous ulcers (n = 25), post-surgical wounds (n = 6) pyoderma gangrenosum (n = 6), vasculitis (n = 1) and pressure ulcer (n = 1). The intensity of pain significantly decreased from the baseline level established at the beginning of treatment (mean score 6.7 − 1.90) - to the level at end of treatment (3.0 − 2.23-; p < 0.0001). 9 patients prematurely stopped the treatment for healing (n = 4), wound improvement (n = 2) and adverse events related to the treatment. (n = 3). 13 patients presented a total of 25 adverse events, 4 of them were related to the treatment. Conclusion: The treatment of painful wounds with 5% Lidocaine Cream for 14 days resulted in reduced pain intensity, and showed high safety and tolerability.
- Published
- 2022